Paul Billings
KGI Bioscience Industry Advisory Board Member, CEO and Director, Biological Dynamics
Dr. Billings has devoted his life to studying and teaching medicine and genetics, while accelerating the use of a broad range of novel genomic technologies in clinical settings. Over his decades in healthcare, he has established key business partnerships, driving adoption of innovative discoveries and commercial success. His leadership has been demonstrated by notable achievements—physician, researcher, founder, senior executive or director of multiple public and private companies, and scientific advisor for government entities.
Dr. Billings has held academic appointments at Harvard University, U.C. San Francisco, Stanford University, and U.C. Berkeley; and served as a board-certified internist and medical geneticist at leading medical centers. He has authored more than 225 scientific and medical publications. His published doctoral studies at Harvard were supervised by Dr. Baruj Benacerraf, who subsequently received the Nobel Prize in Medicine. In addition, he has served on the Scientific Advisory Board of the Food and Drug Administration (FDA), the Genomic Medicine Advisory Committee at the Department of Veterans Affairs, and as an appointee to the Secretary’s Advisory Committee on Genetics, Health, and Society at the Department of Health and Human Services. His work on genetic discrimination was instrumental in the creation and passage of the federal Genetic Information Non-Discrimination Act of 2008. He holds an MD and a PhD in Immunology from Harvard, and an Artium Baccalaureus, summa cum laude from U.C. San Diego.